InvestorsHub Logo
Followers 7
Posts 637
Boards Moderated 0
Alias Born 07/13/2003

Re: worktoplay post# 18513

Monday, 10/25/2004 10:51:48 PM

Monday, October 25, 2004 10:51:48 PM

Post# of 82595
W2P... When I read that I kept thinking....high efficacy success in phase III trials could speed up FDA approval...like other new drugs that showed radically improved treatment responses and got "fast tracked" to market because the benefits outweighed the need to contine the clinical trials...

I do like the "extremely low development risk"...."very confident we will be able to bring to market...".

Nothing like having a relatively safe product so early in the game...

All good news for DNAP and Biofrontera...

God Bless and take care,

Robert